Veltex Corporation
Veltex Corporation focuses on the development and acquisition of companies that have modalities in the areas of health, wellness, and recovery. Its target markets include rehab and treatment centers. The company was founded in 1987 and is headquartered in Chicago, Illinois.
Veltex Corporation (VLXC) - Net Assets
Latest net assets as of June 2025: $-1.99 Million USD
Based on the latest financial reports, Veltex Corporation (VLXC) has net assets worth $-1.99 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.95 Million) and total liabilities ($3.93 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.99 Million |
| % of Total Assets | -101.97% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 215.09 |
Veltex Corporation - Net Assets Trend (2001–2023)
This chart illustrates how Veltex Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Veltex Corporation (2001–2023)
The table below shows the annual net assets of Veltex Corporation from 2001 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-1.07 Million | -84.77% |
| 2022-12-31 | $-581.34K | -379.31% |
| 2021-12-31 | $208.13K | +258.27% |
| 2017-12-31 | $-131.50K | -22.97% |
| 2016-12-31 | $-106.94K | -100.21% |
| 2006-12-31 | $50.08 Million | +15.85% |
| 2005-12-31 | $43.23 Million | +282.87% |
| 2002-12-31 | $11.29 Million | +36.28% |
| 2001-12-31 | $8.28 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Veltex Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 569.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $16.03 Million | % |
| Total Equity | $-1.07 Million | 100.00% |
Veltex Corporation Competitors by Market Cap
The table below lists competitors of Veltex Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Dasheng Biotechnology Company
PINK:CDBT
|
$559.38 |
|
AFRICA EATS LTD (USD)
SEM:EATS
|
$560.06 |
|
TANFIELD GRP
BE:XS3A
|
$560.30 |
|
Gateway Bank F.S.B.
PINK:GWBK
|
$561.38 |
|
Egyptian Arabian(Themar)Comp. For Securities&Bonds Brok. EAC
EGX:EASB
|
$557.12 |
|
Xebra Brands Ltd
OTCQB:XBRAF
|
$556.66 |
|
PP LONDON SUMATRA (PS9A.SG)
STU:PS9A
|
$555.60 |
|
Murray Income Trust Plc
OTCQB:MRRYF
|
$554.49 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Veltex Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -581,337 to -1,074,108, a change of -492,771.
- Net loss of 1,063,065 reduced equity.
- Other factors increased equity by 570,294.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.06 Million | -98.97% |
| Other Changes | $570.29K | +53.09% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Veltex Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $0.00 | $0.06 | x |
| 2002-12-31 | $0.00 | $0.06 | x |
| 2005-12-31 | $0.00 | $0.06 | x |
| 2006-12-31 | $0.00 | $0.06 | x |
| 2021-12-31 | $0.00 | $0.06 | x |
| 2022-12-31 | $-0.01 | $0.06 | x |
| 2023-12-31 | $-0.01 | $0.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Veltex Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -147.75%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-164.87%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 15.86% | 15.03% | 0.79x | 1.34x | $485.34K |
| 2002 | 14.64% | 11.89% | 0.91x | 1.36x | $524.43K |
| 2005 | 30.59% | 19.23% | 1.50x | 1.06x | $8.90 Million |
| 2006 | 11.07% | 7.91% | 1.31x | 1.07x | $537.06K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-994.30K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.82 Million |
| 2021 | -1556.01% | -83296.58% | 0.00x | 7.14x | $-3.26 Million |
| 2022 | 0.00% | -12612.50% | 0.02x | 0.00x | $-3.83 Million |
| 2023 | 0.00% | -147.75% | 0.40x | 0.00x | $-955.65K |
Industry Comparison
This section compares Veltex Corporation's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Veltex Corporation (VLXC) | $-1.99 Million | 15.86% | N/A | $559.32 |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |